Executives at pharmaceutical firms tasked with developing lifesaving drugs for the coronavirus — and receiving billions of dollars in federal funding — are taking home multimillion-dollar compensation packages even before their companies produce a working treatment.
Trending:
Pharmaceutical executives are getting multimillion-dollar payouts — without even producing a vaccine